The Ultimate Resource for Pharmaceutical SOPs and Best Practices
Protocol for Monitoring Study Progress and Data Quality in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to define procedures for conducting interim analysis and monitoring data quality during the course of Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel involved…
Protocol for Ensuring Insurance Protection of Study Participants Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for providing insurance coverage to participants enrolled in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring their protection against study-related injuries or adverse events. Scope This SOP applies to all study personnel involved in participant…
Read More “SOP for Insurance Coverage for Study Participants” »
Protocol for Monitoring Drug Safety in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for monitoring and reporting adverse events, serious adverse events, and other safety-related information in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all study personnel…
Protocol for Managing Safety Information in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the collection, evaluation, documentation, and reporting of safety data related to Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel involved in safety data…
Protocol for Handling Returned and Expired Drugs in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for the proper handling, documentation, and disposal of returned, expired, or unused investigational drugs used in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to…
Protocol for Managing Participant Withdrawals in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for handling participant dropouts and withdrawals from Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all study personnel involved in participant recruitment, enrollment, and study conduct,…
Protocol for Implementing CAPA in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for identifying, implementing, and verifying corrective and preventative actions (CAPA) to address non-conformities, deficiencies, and potential risks identified during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies…
Read More “SOP for Corrective and Preventative Actions (CAPA)” »
Protocol for Addressing Audit Observations in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for responding to audit findings and implementing corrective actions to address deficiencies identified during audits of Bioavailability (BA) and Bioequivalence (BE) study facilities in the pharmaceutical industry. Scope This SOP applies to all…
Protocol for Conducting Audits in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for conducting audits of clinical and bioanalytical facilities involved in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in auditing activities, including Auditors,…
Read More “SOP for Auditing Clinical and Bioanalytical Facilities” »
Protocol for Managing Conflict of Interest in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the identification, disclosure, and management of conflicts of interest among personnel involved in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel, including…